The efficacy and safety of microwave ablation in patients with retroperitoneal metastases

References

• Machi J, Oishi AJ, Furumoto NL, Oishi RH. (2003). Sonographically guided radio-frequency thermal ablation for unresectable recurrent tumors in the retroperitoneum and the pelvis. J Ultrasound Med 22:507–13.
   PubMed Web of Science ®Google Scholar
• Keil S, Bruners P, Brehmer B, Mahnken AH. (2008). Percutaneous radiofrequency ablation for treatment of recurrent retroperitoneal liposarcoma. Cardiovasc Intervent Radiol 31:S213–S6.
   PubMedGoogle Scholar
• Narayanan G, Bhatia S, Echenique A, et al. (2014). Vessel patency post irreversible electroporation. Cardiovasc Intervent Radiol 37:1523–9.
   PubMed Web of Science ®Google Scholar
• Gill IS, Novick AC, Meraney AM, et al. (2000). Laparoscopic renal cryoablation in 32 patients. Urology 56:748–53.
   PubMed Web of Science ®Google Scholar
• Lee DI, McGinnis DE, Feld R, Strup SE. (2003). Retroperitoneal laparoscopic cryoablation of small renal tumors: intermediate results. Urology 61:83–8.
   PubMed Web of Science ®Google Scholar
• Kariya S, Tanigawa N, Kojima H, et al. (2005). Radiofrequency ablation combined with CO2 injection for treatment of retroperitoneal tumor: protecting surrounding organs against thermal injury. Am J Roentgenol 185:890–3.
   PubMed Web of Science ®Google Scholar
• Patel MN, Menon M, Rogers CG. (2008). Robot-assisted retroperitoneal renal cryoablation. J Robot Surg 2:257.
   PubMedGoogle Scholar
• Arellano RS, Flanders VL, Lee SI, et al. (2010). Imaging-guided percutaneous radiofrequency ablation of retroperitoneal metastatic disease in patients with gynecologic malignancies: clinical experience with eight patients. Am J Roentgenol 194:1635–8.
   PubMed Web of Science ®Google Scholar
• Wan ZH, Bai QY. (2011). Focused ultrasound in patients with primary retroperitoneal sarcoma therapy. Chinese J Hernia Abdom Wall Surg 5:49–52.
   Google Scholar
• Gao F, Gu Y, Huang J, et al. (2012). Radiofrequency ablation of retroperitoneal metastatic lymph nodes from hepatocellular carcinoma. Acad Radiol 19:1035–40.
   PubMed Web of Science ®Google Scholar
• Dusaud M, Malavaud B, Bayoud Y, et al. (2016). Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study J Surg Oncol 114:992–6.
   PubMed Web of Science ®Google Scholar
• MacNeill AJ, Gronchi A, Miceli R, et al. (2017). Postoperative morbidity after radical resection of primary retroperitoneal sarcoma: a report from the transatlantic RPS working group. Ann Surg. [Epub ahead of print]. doi:10.1097/SLA.0000000000002250.
   PubMed Web of Science ®Google Scholar
• MacNeill AJ, Miceli R, Strauss DC, et al. (2017). Post-relapse outcomes after primary extended resection of retroperitonealsarcoma: a report from the trans-atlantic RPS working group. Cancer 123:1971–8.
   PubMed Web of Science ®Google Scholar
• Gershman B, Takahashi N, Moreira DM, et al. (2016). Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model. BJU Int 118:742–9.
   PubMed Web of Science ®Google Scholar
• Ju X, Li P, Shao P, et al. (2016). Retroperitoneal laparoscopic nephrectomy combined with bench surgery and autotransplantation for renal cell carcinoma in the solitary kidney or tumor involving bilateral kidneys: Experience at a single center and technical considerations. Urol Int 97:473–9.
   PubMed Web of Science ®Google Scholar
• Rungruang BJ, Miller A, Krivak TC, et al. (2017). What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Groupancillary data study. Cancer 123:985–93.
   PubMed Web of Science ®Google Scholar
• Yang X, Ye X, Huang G, et al. (2017). Repeated percutaneous microwave ablation for local recurrence of inoperable Stage I nonsmall cell lung cancer. J Cancer Res Ther 13:683–8.
   PubMed Web of Science ®Google Scholar
• Li W, Man W, Guo H, Yang P. (2016). Clinical study of transcatheter arterial chemoembolization combined with microwave ablation in the treatment of advanced hepatocellular carcinoma. J Cancer Res Ther 12(Suppl):C217–20.
   PubMed Web of Science ®Google Scholar
• Kim C, Hoang CD, Kesarwala AH, et al. (2017). Role of local ablative therapy in patients with oligometastatic and oligoprogressive non-small cell lung cancer. J Thorac Oncol 12:179–93.
   PubMed Web of Science ®Google Scholar
• de Baere T, Tselikas L, Catena V, et al. (2016). Percutaneous thermal ablation of primary lung cancer. Diagn Interv Imaging 97:1019–24.
   PubMed Web of Science ®Google Scholar
• Howard J, Masterson L, Dwivedi RC, et al. (2016). Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma. Cochrane Database Syst Rev 12:CD010963.
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Serviddio G, Muscatiello N. (2016). Local ablative treatments for hepatocellular carcinoma: an updated review. World J Gastrointest Pharmacol Ther 7:477–89.
   PubMedGoogle Scholar
• Lucchina N, Tsetis D, Ierardi AM, et al. (2016). Current role of microwave ablation in the treatment of small hepatocellular carcinomas. Ann Gastroenterol 29:460–5.
   PubMed Web of Science ®Google Scholar
• Floridi C, De Bernardi I, Fontana F, et al. (2014). Microwave ablation of renal tumors: state of the art and development trends. Radiol Med 119:533–40.
   PubMed Web of Science ®Google Scholar
• Sidoff L, Dupuy DE. (2017). Clinical experiences with microwave thermal ablation of lung malignancies. Int Hyperthermia 33:25–33.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu X, Liang P, et al. (2016). Combined microwave ablation and systemic chemotherapy for liver metastases from oesophageal cancer: preliminary results and literature review. Int J Hyperthermia 32:524–30.
   PubMed Web of Science ®Google Scholar
• Nour-Eldin NA, Exner S, Al-Subhi M, et al. (2017). Ablation therapy of non-colorectal cancer lung metastases: retrospectiveanalysis of tumour response post-laser-induced interstitial thermotherapy (LITT), radiofrequency ablation (RFA) and microwave ablation (MWA). Int J Hyperthermia 33:820–9.
   PubMed Web of Science ®Google Scholar
• Singla N, Gahan J. (2016). New technologies in tumor ablation. Curr Opin Urol 26:248–53.
   PubMed Web of Science ®Google Scholar
• Poulou LS, Botsa E, Thanou I, et al. (2015). Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Hepatol 7:1054–63.
   PubMed Web of Science ®Google Scholar
• Edeline J, Palmer D, Blanc JF, et al. (2017). mRECIST for systemic therapies: more evidence is required before recommendations can be made. J Hepatol S0168-8278:30135–6.
   Google Scholar
• Clarecon F, Jean B, Pham HP, et al. (2013). Value of percutaneous radiofrequency ablation with or without percutaneous vertebroplasty for pain relief and functional recovery in painful bone metastases. Skelet Radiol 42:25–36.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. (2014). Image-guided tumor ablation: standardization of terminology and reporting criteria – a 10-year update. Radiology 273:241–60.
   PubMed Web of Science ®Google Scholar
• Ye X, Fan W, Chen JH, et al. (2015). Chinese expert consensus workshop report: guidelines for thermal ablation of primary and metastatic lung tumors. Thorac Cancer 6:112–21.
   PubMed Web of Science ®Google Scholar
• Fan W, Niu L, Wang Y, et al. (2016). Percutaneous computed tomography-guided cryoablation for recurrent retroperitoneal soft tissue sarcoma: a study of safety and efcacy. Oncotarget 7:42639–49.
   PubMed Web of Science ®Google Scholar
• Mou Y, Zhao Q, Zhong L, et al. (2016). Preliminary results of ultrasound-guided laser ablation for unresectablemetastases to retroperitoneal and hepatic portal lymph nodes. World J Surg Oncol 14:165.
   PubMed Web of Science ®Google Scholar
• Jiang T, Deng Z, Tian G, et al. (2017). Percutaneous laser ablation: new contribution to unresectable high-risk metastatic retroperitoneal lesions. Oncotarget 8:2413–22.
   PubMed Web of Science ®Google Scholar
• Zhao M, Li X, Wang J, et al. (2012). Retroperitoneal schwannoma treated with percutaneous computed tomography-guided radiofrequency ablation. J Neurosurg Spine 17:173–6.
   PubMed Web of Science ®Google Scholar
• Littrup PJ, Bang HJ, Currier BP, et al. (2013). Soft-tissue cryoablation in difuse locations: feasibility and intermediate term outcomes. J Vasc Interv Radiol 24:1817–25.
   PubMed Web of Science ®Google Scholar
• Araujo LH, Gouveia HR, Freitas Ede Q, et al. (2013). Hepatic transarterial chemoembolization and retroperitoneal lymph node radiofrequency ablation in the multidisciplinary approach of an overt metastatic leiomyosarcoma. Cancer Imaging 13:123–7.
   PubMed Web of Science ®Google Scholar
• Molina R, Alvarez M, Capilla J, Paez A. (2014). Radiofrequency-treated recurrence of urothelial carcinoma of the upper urinary tract after nephroureterectomy. Korean J Urol 55:844–6.
   PubMedGoogle Scholar
• Monfardini L, Varano GM, Foa R, et al. (2015). Local recurrence of renal cancer after surgery: prime time for percutaneous thermal ablation. Cardiovasc Intervent Radiol 38:1542–7.
   PubMed Web of Science ®Google Scholar
• Underhill CE, Walsh NJ, Bateson BP, et al. (2016). Feasibility and safety of irreversible electroporation in locally advanced pelvic and retroperitoneal tumors. Am Surgeon 82:263–5.
   PubMed Web of Science ®Google Scholar
• Mannion RJ, Woolf CJ. (2000). Pain mechanisms and management: a central perspective. Clin J Pain 16:S144–S56.
   PubMed Web of Science ®Google Scholar
• Honore P, Luger NM, Sabino MA, et al. (2000). Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat Med 6:521–8.
   PubMed Web of Science ®Google Scholar